Navigation Menu

Advarra Expert Discusses Latest FDA Guidance on COVID

Tuesday, March 24, 2020 | 12:00AM EDT

Time Left00day00 hrs00 min00 sec

James Riddle, Advarra's Vice President of Institutional Services, provides his insights on how his IRB is responding to covid-related requests, the recent rise of virtual and at-home visits, and how the FDA's most recent guidance offers flexibility to sponsors and sites alike.
  • Who is this for?
  • What is the duration?
  • What can I learn from this?

Advarra is the largest central IRB for pharmaceutical trials. Learn from Advarra's Vice President of Institutional Services what challenges the industry is facing; how to assess patient safety risks; what steps Advarra is taking; what specific actions sponsors and investigators should consider; and how to interpret the FDA's March, 2020 guidance on the covid crisis.

Date:March 24, 2020
Time:12:00 AM EDT
Duration:20 min
Speaker: James Riddle
Topic: Clinical Trial Site Operations
Meet the Speakers

James Riddle

James Riddle

James has served on the board of the Northwest Association for Biomedical Research (NWABR) and the steering committee of the Clinical Trials Transformation Initiative (CTTI). He has also served as a site visitor for the Association for the Accreditation of Human Research Protection Programs (AAHRPP). In addition to being on the editorial board of the journal IRB Advisor and the leadership team for the Alliance for Clinical Research Excellence and Safety (ACRES) Committee on Accreditation, he is a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R) and other industry conferences.

Learning Objectives
Balance patient safety with protocol compliance
Adopt virtual or at-home visits as alternatives
Document what actions you took and what impact they had on patient safety and data integrity
View Webinar